AK Medical
AK Medical, officially known as AK Medical Holdings Limited, is a leading player in the orthopaedic medical device industry, headquartered in China. Established in 2002, the company has made significant strides in the development and manufacturing of innovative orthopaedic implants and instruments, primarily serving the Asia-Pacific region and expanding its reach globally. Specialising in joint replacement and trauma products, AK Medical is recognised for its commitment to quality and advanced technology, which sets its offerings apart in a competitive market. The company has achieved notable milestones, including various certifications and partnerships that enhance its market position. With a focus on research and development, AK Medical continues to deliver unique solutions that improve patient outcomes and solidify its reputation as a trusted name in orthopaedics.
DitchCarbon Score
How does AK Medical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
AK Medical's score of 19 is lower than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
AK Medical's reported carbon emissions
In 2023, AK Medical, headquartered in China (CN), reported no specific carbon emissions data. However, the company has disclosed its Scope 2 emissions intensity, which stands at approximately 5.0 kg CO2e per unit of revenue (CNY) for the year. This figure reflects the indirect emissions associated with the electricity consumed in its operations. Looking back at 2022, AK Medical's Scope 2 emissions intensity was about 4.0 kg CO2e per unit of revenue (CNY), indicating a slight increase in emissions intensity year-on-year. In 2021, the company reported a similar Scope 2 emissions intensity of approximately 5.0 kg CO2e per unit of revenue (CNY). For the year 2018, AK Medical disclosed comprehensive emissions data, reporting total emissions of 99300 kg CO2e for Scope 1, 1514900 kg CO2e for Scope 2, and 3693100 kg CO2e for Scope 3. This data highlights the company's overall carbon footprint, with Scope 3 emissions being the most significant contributor. Despite these figures, AK Medical has not set any specific reduction targets or climate pledges, nor does it appear to inherit emissions data from a parent company. The absence of formal commitments or targets suggests that the company may need to enhance its climate strategy to align with industry standards and expectations for sustainability.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | |
|---|---|---|
| Scope 1 | 242,600 | 00,000 |
| Scope 2 | 1,185,000 | 0,000,000 |
| Scope 3 | 1,427,600 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
AK Medical is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
